Used to display related News & Events articles on the Raising Awareness page.
By Prof. Jeremy Teoh, Dr Makarand Khochikar and Alex Filicevas
Every year, 635,264 people around the world are told they have bladder cancer. That is more than one person every minute, each with a family, a job and a life that the diagnosis suddenly puts on hold. Around 2 million people are living with bladder cancer today, making it the eighth most common cancer worldwide.
In September 2026,
Today, on World Mental Health Day, we are launching our new factsheet, Mental Health and Emotional Well-being. Written for patients, survivors and carers, it recognises that bladder cancer affects the mind as well as the body, and offers practical support for both.
This year’s theme, set by the World Federation for Mental Health and promoted by the World Health Organization, is “Lived Experiences Heard: Real Voices,
European Carers Day, an initiative of Eurocarers, is marked every year on October 6 to recognise the millions of people across Europe who care for a family member, friend or neighbour. This year, we join Eurocarers in highlighting a challenge shared by many carers of people affected by bladder cancer: balancing paid work with caring. Last year, our focus was on making migrant care visible, respected and protected.
Advocates Day at the World Bladder Cancer Patient Forum 2026 in Hong Kong made room for a subject every organisation in the room is already wrestling with. In a workshop titled “AI tools for patient advocates: a practical introduction” Theodoros Yfantis, WBCPC Project Coordinator, set out where artificial intelligence can genuinely help an advocacy team, and where it should be kept well away.
He began by taking the mystery out of it.
Advocates Day at the World Bladder Cancer Patient Forum 2026 in Hong Kong turned to what members have actually built, with four organisations presenting projects that worked at home and could work elsewhere. None of us holds a monopoly on good ideas, and the session ran on a simple assumption: the most useful resource in the room is often something another member has already tried.
The World Bladder Cancer Patient Coalition (WBCPC) has expanded its Italian-language resources with the publication of its full series of bladder cancer factsheets, supporting access to reliable, patient-friendly information for Italian-speaking communities.
This work builds on WBCPC’s ongoing collaboration with our member organisation PaLiNUro, whose expertise and local insight have been central to ensuring the factsheets are accurate, accessible and relevant for patients and families in Italy.
Access to clear information remains a key challenge for many people affected by bladder cancer,
Someone notices blood in their urine. They tell themselves it is probably nothing, and they wait. For too many people, that wait is the difference between catching bladder cancer early and catching it too late.
Each May, Bladder Cancer Awareness Month (BCAM) brings our global community together to change that. Bladder cancer is one of the most common cancers in the world, yet one of the most overlooked. With 1.9 million people living with bladder cancer and 614,298 people newly diagnosed each year,
Our bladder cancer treatment factsheets are now available in Arabic. This brings clear, trusted information to Arabic-speaking patients, survivors and carers around the world.
The factsheets cover two types of bladder cancer:
A bladder cancer diagnosis can be hard to take in, and treatment choices are not always easy to understand. These factsheets explain the essentials simply,
We have just launched a new printable schedule to help you keep track of your BCG treatment for bladder cancer, all on two simple pages. It gives you and your care team one clear place to note every session and every check-up, so nothing slips through the cracks. Print it, keep it handy, and bring it to each appointment. That is all there is to it.
Here is why it helps.
We are pleased to share that our patient information factsheet “Understanding BCG treatment for bladder cancer” is now available in Spanish and French, alongside the English version launched last month.
The factsheet is the ninth patient information factsheet in our series for patients and carers. It explains Bacillus Calmette-Guérin (BCG), one of the most common treatments for non-muscle-invasive bladder cancer (NMIBC), in clear and simple terms.
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
